BMJ Case Rep - The Consciousness Library

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants.

BMJ Case Rep July 15, 2019 Ben Sessa, Chloe Sakal, Steve O’Brien et al. 55 citations

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants.

DOI: 10.1136/bcr-2019-230109 Full text Psychedelic therapy Alcohol use disorder MDMA Therapy MDMA-Assisted Psychotherapy +14

Papers

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants.